The Failure and Potential of Home Diagnostics
Even for experienced companies, home testing has been a tough business, and expectations set by the success of blood glucose monitoring and pregnancy have been impossible for other tests to meet.
You may also be interested in...
Agency officials can now discuss the ideas that have been accepted, though not in great detail.
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.